[HTML][HTML] Advanced nanocarrier-and microneedle-based transdermal drug delivery strategies for skin diseases treatment

F Qu, R Geng, Y Liu, J Zhu - Theranostics, 2022 - ncbi.nlm.nih.gov
Skin diseases are the fourth leading cause of nonfatal and chronic skin diseases, acting as a
global burden and affecting the world economy. Skin diseases severely impact the patients' …

[HTML][HTML] Overcoming drug delivery barriers and challenges in topical therapy of atopic dermatitis: A nanotechnological perspective

C Hemrajani, P Negi, A Parashar, G Gupta… - Biomedicine & …, 2022 - Elsevier
Atopic dermatitis (AD) is an inflammatory disorder centered around loss of epidermal barrier
function, and T helper 2 (Th2) immune responses. The current understanding of disease …

[HTML][HTML] Nanocarrier-based dermopharmaceutical formulations for the topical management of atopic dermatitis

AC Paiva-Santos, M Gama, D Peixoto… - International journal of …, 2022 - Elsevier
Atopic dermatitis (AD) is a chronic disease that affects the skin, and that is characterized by
highly itchy inflammation, frequent eczematous lesions, and a fluctuating course. The current …

Nano intervention in topical delivery of corticosteroid for psoriasis and atopic dermatitis—a systematic review

K Shetty, AP Sherje - Journal of Materials Science: Materials in Medicine, 2021 - Springer
Atopic dermatitis (AD) and psoriasis are highly prevalent, complex, chronic inflammatory
skin diseases that immensly affect the patient's quality of life. While there is no definitive cure …

Therapeutic potential of microneedles based delivery systems for the management of atopic dermatitis

S Shukla, KB Mamale, RKK Arya, RK Kaundal… - Journal of Drug Delivery …, 2023 - Elsevier
Atopic Dermatitis (AD) is a diverse skin condition with a range of shapes, localization, and
progression of the disease. Even though its pathophysiology is multifaceted and not entirely …

Trends in nanoformulations for atopic dermatitis treatment

EV Ramos Campos, PLDF Proença… - Expert Opinion on …, 2020 - Taylor & Francis
Introduction Immunological skin dysfunctions trigger the synthesis and release of
inflammatory cytokines, which induce recurrent skin inflammation associated with chronic …

Emerging nanomedicines for the treatment of atopic dermatitis

K Parekh, TA Mehta, N Dhas, P Kumar, A Popat - Aaps Pharmscitech, 2021 - Springer
Globally, the prevalence of Atopic dermatitis (AD) is significantly increasing and affecting
around 20% of population including children. Complex interactions amongst abnormality in …

[HTML][HTML] Polysaccharide-based hydrogels for atopic dermatitis management: A review

H Rao, JBL Tan - Carbohydrate Polymers, 2024 - Elsevier
Atopic dermatitis (AD) is the most common form of eczema and the most burdensome skin
disease globally, affecting nearly 223 million. A major AD predisposition is genetic …

Recent advances in nanocarrier-based approaches to atopic dermatitis and emerging trends in drug development and design

Amisha, D Singh, BD Kurmi, A Singh - Current Drug Delivery, 2024 - benthamdirect.com
Atopic dermatitis (AD), commonly known as Eczema, is a non-communicable skin condition
that tends to become chronic. The deteriorating immunological abnormalities are marked by …

Hydrogels: a promising vehicle for the topical management of atopic dermatitis

AI Barbosa, T Torres, SAC Lima… - Advanced …, 2021 - Wiley Online Library
Atopic dermatitis (AD) is an inflammatory skin disease with a high worldwide prevalence. AD
is characterized by fluctuating and recurrent eczematous lesions and intense itch, being …